Shareholder Votes

Biofrontera Inc. shareholders approved Stockholders elected Beth J. Hoffman, Ph.D. and Kevin D. Weber to serve as Class II directors of the Company until the 2029 Annual Meeting of Stockholders and until his or her successor has been duly elected and qualified, or until his or her earlier death, resignation, or removal. at the 2026-06-11 meeting.

“Stockholders elected Beth J. Hoffman, Ph.D. and Kevin D. Weber to serve as Class II directors of the Company until the 2029 Annual Meeting of Stockholders and until his or her successor has been duly elected and qualified, or until his or her earlier death, resignation, or removal. The tabulation of votes cast was as follows: Beth J. Hoffman, Ph.D. For Withheld Broker Non-Votes 8,089,416 221,060 3,319,657 Kevin D. Weber For Withheld Broker Non-Votes 8,203,433 107,043 3,319,657”

Insight Molecular Diagnostics Inc. shareholders approved To approve an amendment to the Amended and Restated 2018 Equity Incentive Plan to increase the total number of shares of the Company’s common stock authorized for issuance under the Incentive Plan by 1,750,000, to a total of 5,550,000 shares at the 2026-06-11 meeting.

“Approval of Amendment to Incentive Plan Shares Non-Votes 19,117,865 122,829 4,799 4,708,719”

Insight Molecular Diagnostics Inc. shareholders approved To approve, on a non-binding advisory basis, the Company’s named executive officer compensation for the year ended December 31, 2025 at the 2026-06-11 meeting.

“Say On Pay Proposal Shares Non-Votes 19,199,697 26,126 19,679 4,708,719”

Insight Molecular Diagnostics Inc. shareholders approved To ratify the appointment of CBIZ CPAs P.C. as the Company’s independent registered public accounting firm for the year ending December 31, 2026 at the 2026-06-11 meeting.

“Ratification of Appointment of Accounting Firm Shares Non-Votes 23,949,191 2,420 2,601 0”

Insight Molecular Diagnostics Inc. shareholders approved To elect the following four (4) director nominees, each to serve until the 2027 annual meeting of shareholders and until his successor has been elected and qualified, or until his earlier death, resignation, or removal: Joshua Riggs, Andrew Arno, Andrew J. Last and Louis E. Silverman at the 2026-06-11 meeting.

“Shares Voted Director Nominee For Against Abstained Broker Non-Votes Joshua Riggs 19,239,253 2,420 3,820 4,708,719 Andrew Arno 19,100,993 140,445 4,056 4,708,719 Andrew J. Last 19,237,621 3,938 3,935 4,708,719 Louis E. Silverman 19,224,148 17,290 4,056 4,708,719”

Alector, Inc. shareholders approved Advisory Vote on Executive Compensation at the 2026-06-17 meeting.

“3. Stockholders approved, on a non-binding advisory basis, the compensation of Alector’s named executive officers as disclosed in the proxy statement for the Annual Meeting, known as the Say-on-Pay vote. The voting results were as follows: Votes For Votes Against Abstentions Broker Non-Vote 58,652,335 2,492,538 11,082 36,697,144”

Alector, Inc. shareholders approved Ratification of Independent Registered Public Accounting Firm at the 2026-06-17 meeting.

“2. Stockholders ratified the appointment of Ernst & Young LLP as Alector’s independent registered accounting firm for the fiscal year ending December 31, 2026. The voting results were as follows: Votes For Votes Against Abstentions Broker Non-Vote 97,717,750 52,302 83,047 0”

Alector, Inc. shareholders approved Election of Class II Directors at the 2026-06-17 meeting.

“1. The Class II director nominees were elected to serve until Alector’s 2029 annual meeting of stockholders and until their successors are elected and qualified. The voting results were as follows: Director Name Votes For Votes Withheld Broker Non-Vote Elizabeth Garofalo, M.D. 60,256,636 899,318 36,697,144 Errol De Souza, Ph.D. 60,461,939 694,016 36,697,144 Kristine Yaffe, M.D. 45,733,503 15,422,452 36,697,144”

AEON Biopharma, Inc. shareholders approved Ratification of appointment of KPMG LLP as independent registered public accounting firm for fiscal year 2026 at the 2026-06-17 meeting.

“Proposal 2: The stockholders of the Company ratified the appointment of KPMG LLP as the Company’s independent registered public accounting firm for the fiscal year ended December 31, 2026. The voting results for this proposal were as follows: ​ ​ ​ ​ ​ ​ ​ For ​ Against ​ Abstain ​ Broker Non-Vote 21,502,418 ​ 18,217 ​ 1,498 ​ —”

AEON Biopharma, Inc. shareholders approved Election of Class III Directors at the 2026-06-17 meeting.

“Proposal 1: The stockholders of the Company elected each of Marc Forth and Seongsoo Park as Class III directors of the Company’s board of directors (the “Class III Directors”) for a three-year term ending at the Annual Meeting of Stockholders to be held in 2029 and until their respective successors have been duly elected and qualified. The voting results with respect to the election of the Class III Directors were as follows: ​ ​ ​ ​ ​ ​ ​ ​ ​ Nominee ​ Term Expiring ​ For ​ Withheld ​ Broker Non-Vote Marc Forth ​ 2029 ​ 13,297,322 ​ 27,738 ​ 8,197,073 Seongsoo Park ​ 2029 ​ 13,117,299 ​ 207,761 ​ 8,197,073”

Mastercard Inc shareholders rejected Stockholder proposal to adopt cumulative voting for the election of directors at the 2026-06-16 meeting.

“5. The holders of Class A common stock did not approve the stockholder proposal to adopt cumulative voting for the election of directors: For Against Abstain Broker Non-Votes 22,939,249 715,414,648 2,549,641 44,449,009”

Mastercard Inc shareholders rejected Stockholder proposal regarding shareholder right to act by written consent at the 2026-06-16 meeting.

“4. The holders of Class A common stock did not approve the stockholder proposal regarding shareholder right to act by written consent: For Against Abstain Broker Non-Votes 219,787,693 509,604,992 11,510,853 44,449,009”

Mastercard Inc shareholders approved Ratification of PricewaterhouseCoopers LLP as independent registered public accounting firm for 2026 at the 2026-06-16 meeting.

“3. The holders of Class A common stock ratified the appointment of PricewaterhouseCoopers LLP as Mastercard’s independent registered public accounting firm for 2026: For Against Abstain 726,095,824 58,529,894 726,829”

Mastercard Inc shareholders approved Advisory approval of Mastercard's executive compensation at the 2026-06-16 meeting.

“2. The holders of Class A common stock approved, on an advisory basis, Mastercard's executive compensation: For Against Abstain Broker Non-Votes 701,046,392 38,008,152 1,848,994 44,449,009”

Mastercard Inc shareholders approved Election of eleven directors to serve for a one-year term expiring on the date of Mastercard's 2027 annual meeting of stockholders at the 2026-06-16 meeting.

“1. The holders of Class A common stock elected the following individuals to serve on the Board of Directors of Mastercard as directors for a one-year term expiring on the date of Mastercard’s 2027 annual meeting of stockholders: Director For Against Abstain Broker Non-Votes Merit E. Janow 695,415,065 44,318,497 1,169,976 44,449,009 Candido Bracher 737,012,116 3,374,634 516,788 44,449,009 Richard K. Davis 716,683,376 23,716,649 503,513 44,449,009 Julius Genachowski 660,087,381 79,711,538 1,104,619 44,449,009 Choon Phong Goh 692,891,922 47,493,724 517,892 44,449,009 Oki Matsumoto 702,316,747 38,064,923 521,868 44,449,009 Michael Miebach 735,911,895 4,344,270 647,373 44,449,009 Youngme Moon 738,673,930 1,714,463 515,145 44,449,009 Gabrielle Sulzberger 730,415,514 9,601,529 886,495 44,449,009 Harit Talwar 735,808,207 4,575,870 519,461 44,449,009 Lance Uggla 723,551,911 16,821,430 530,197 44,449,009”

ROKU, INC shareholders approved Ratification of Deloitte & Touche LLP as independent registered accounting firm at the 2026-06-11 meeting.

“3. Stockholders ratified the appointment of Deloitte & Touche LLP as Roku’s independent registered accounting firm for the fiscal year ending December 31, 2026. The voting results were as follows: Votes For Votes Against Abstentions Percentage of Votes in Favor 268,465,112 937,194 363,976 99.5%”

ROKU, INC shareholders approved Advisory vote on compensation of named executive officers at the 2026-06-11 meeting.

“2. Stockholders approved, on an advisory basis, the compensation of Roku’s named executive officers, as described in the 2026 Proxy Statement. The voting results were as follows: Votes For Votes Against Abstentions Broker Non-Votes Percentage of Votes in Favor 213,827,937 36,344,270 132,411 19,461,664 85.4%”

ROKU, INC shareholders approved Election of Class III directors at the 2026-06-11 meeting.

“1. The Class III director nominees were elected to serve until Roku’s 2029 annual meeting of stockholders and in each case until their successors are elected and qualified or until their earlier death, resignation, or removal. The voting results were as follows: Director Name Votes For Votes Withheld Broker Non-Votes Percentage of Votes in Favor Jeffrey Hastings 209,675,473 40,629,145 19,461,664 83.8% Neil Hunt 237,465,642 12,838,976 19,461,664 94.9% Anthony Wood 229,758,502 20,546,116 19,461,664 91.8%”

AMC Global Media Inc. shareholders approved Approval of Amended and Restated 2011 Stock Plan for Non-Employee Directors at the 2026-06-16 meeting.

“The Company’s Class A stockholders and Class B stockholders, voting together as a single class, approved a proposal recommending the Company’s Amended and Restated 2011 Stock Plan for Non-Employee Directors. The votes regarding this proposal were as follows: For Against Abstain Broker Non-Votes 132,943,297 3,695,457 10,270 5,599,838”

AMC Global Media Inc. shareholders approved Advisory vote on executive compensation at the 2026-06-16 meeting.

“The Company’s Class A stockholders and Class B stockholders, voting together as a single class, approved, on an advisory basis (non-binding), the compensation of the Company’s Named Executive Officers. The votes regarding this proposal were as follows: For Against Abstain Broker Non-Votes 121,381,952 15,219,121 47,951 5,599,838”

AMC Global Media Inc. shareholders approved Ratification of KPMG LLP as independent registered public accounting firm for 2026 at the 2026-06-16 meeting.

“The Company’s Class A stockholders and Class B stockholders, voting together as a single class, ratified the appointment of KPMG LLP as the Company’s independent registered public accounting firm for the 2026 fiscal year. The votes regarding this proposal were as follows: For Against Abstain Broker Non-Votes 142,138,711 98,835 11,316 0”

AMC Global Media Inc. shareholders approved Election of Directors (Class A and Class B) at the 2026-06-16 meeting.

“The Company’s Class A stockholders elected the three directors listed below to the Board of Directors, each for a one-year term. The votes regarding this proposal were as follows: For Withheld Broker Non-Votes Matthew C. Blank 12,124,766 9,680,178 5,599,838 Debra G. Perelman 12,137,870 9,667,074 5,599,838 Carl E. Vogel 5,853,965 15,950,979 5,599,838 The Company’s Class B stockholders elected the seven directors listed below to the Board of Directors, each for a one-year term. The votes regarding this proposal were as follows: For Withheld Broker Non-Votes James L. Dolan 114,844,080 0 0 Christopher J. Cox 114,844,080 0 0 Aidan J. Dolan 114,844,080 0 0 Kristin Dolan 114,844,080 0 0 Thomas C. Dolan 114,844,080 0 0 Brian G. Sweeney 114,844,080 0 0 Vincent Tese 114,844,080 0 0”

Inmune Bio, Inc. shareholders approved Approval of the Third Amended and Restated INmune Bio Inc. 2021 Stock Incentive Plan at the 2026-06-16 meeting.

“Proposal Three: Approval of the Third Amended and Restated INmune Bio Inc. 2021 Stock Incentive Plan. As noted above, the stockholders approved the Amended Plan. For Against Abstentions Broker Non-Votes 6,085,086 2,775,224 95,367 8,501,317”

Inmune Bio, Inc. shareholders approved Ratification of Appointment of Independent Auditor at the 2026-06-16 meeting.

“Proposal Two: Ratification of Appointment of Independent Auditor. Stockholders approved the ratification of the appointment of CBIZ CPAs P.C. as the Company’s independent auditors for the fiscal year ending December 31, 2026. For Against Abstentions Broker Non-Votes 17,293,255 107,064 56,675 0”

Inmune Bio, Inc. shareholders approved Election of Directors at the 2026-06-16 meeting.

“Proposal One: Election of Directors. Stockholders elected each of the following nominees as directors to hold office until the next meeting of the Company’s stockholders and until his or her successor is elected and qualified. Nominee Votes For Votes Withheld Broker Non-Votes David Moss 6,834,995 2,120,682 8,501,317 J. Kelly Ganjei 5,955,609 3,000,068 8,501,317 Tim Schroeder 6,622,916 2,332,761 8,501,317 Scott Juda, JD 7,508,310 1,447,367 8,501,317 Marcia Allen 6,342,910 2,612,767 8,501,317 1”

Cartesian Therapeutics, Inc. shareholders approved Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026. at the 2026-06-12 meeting.

“Proposal 3 - Ratification of the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2026. Votes FOR Votes AGAINST Votes ABSTAINED Broker Non-Votes 24,144,742 6,157 637 — Based on the votes set forth above, the stockholders ratified the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2026.”

Cartesian Therapeutics, Inc. shareholders approved Approval, on a non-binding and advisory basis, of a resolution approving the compensation of the Company's named executive officers. at the 2026-06-12 meeting.

“Proposal 2 - Approval, on a non-binding and advisory basis, of a resolution approving the compensation of the Company’s named executive officers. Votes FOR Votes AGAINST Votes ABSTAINED Broker Non-Votes 13,659,709 136,217 6,033,199 4,322,411 Based on the votes set forth above, the stockholders approved, on a non-binding and advisory basis, a resolution approving the compensation of our named executive officers.”

Cartesian Therapeutics, Inc. shareholders approved Election of three Class I Directors to serve until the 2029 Annual Meeting of Stockholders, and until their respective successors have been duly elected and qualified. at the 2026-06-12 meeting.

“Proposal 1 - Election of three Class I Directors to serve until the 2029 Annual Meeting of Stockholders, and until their respective successors have been duly elected and qualified. NOMINEE Votes FOR Votes WITHHELD Broker Non-Votes Michael Singer, M.D., Ph.D. 11,745,619 8,083,506 4,322,411 Timothy A. Springer, Ph.D. 18,665,163 1,163,962 4,322,411 Patrick Zenner, M.B.A 12,168,919 7,660,206 4,322,411 Based on the votes set forth above, each director nominee was duly elected to serve until the Company’s 2029 Annual Meeting of Stockholders, and until their respective successors have been duly elected and qualified.”

FORWARD AIR CORP shareholders approved Approval of an Amendment to the 2025 Omnibus Incentive Compensation Plan at the 2026-06-17 meeting.

“Proposal 4: Approval of an Amendment to the 2025 Omnibus Incentive Compensation Plan The Company’s stockholders voted to approve an amendment to the Company’s 2025 Omnibus Incentive Compensation Plan, as set forth below: Votes For Votes Against Abstentions Broker Non-Votes 21,834,532 3,752,547 464,208 4,674,152”

FORWARD AIR CORP shareholders approved Ratification of Appointment of Independent Registered Public Accounting Firm for the 2026 Fiscal Year at the 2026-06-17 meeting.

“Proposal 3: Ratification of Appointment of Independent Registered Public Accounting Firm for the 2026 Fiscal Year The Company’s stockholders ratified the appointment of KPMG LLP as the Company’s independent registered public accounting firm for the 2026 fiscal year, as set forth below: Votes For Votes Against Abstentions 30,503,398 145,356 76,685”

FORWARD AIR CORP shareholders approved Advisory Vote on Compensation of Named Executive Officers at the 2026-06-17 meeting.

“Proposal 2: Advisory Vote on Compensation of Named Executive Officers The Company’s stockholders voted to approve, on a non-binding, advisory basis, the compensation of the Company’s named executive officers, as set forth below: Votes For Votes Against Abstentions Broker Non-Votes 24,784,242 1,130,305 136,740 4,674,152”

FORWARD AIR CORP shareholders approved Election of Directors at the 2026-06-17 meeting.

“Proposal 1: Election of Directors The Company’s stockholders elected five individuals to the Board of Directors, as set forth below: Votes For Votes Withheld Broker Non-Votes Dale W. Boyles 21,374,787 4,676,500 4,674,152 Christine M. Gorjanc 21,556,278 4,495,009 4,674,152 Jerome Lorrain 21,499,588 4,551,699 4,674,152 Shawn Stewart 25,370,833 680,454 4,674,152 Paul Svindland 21,569,237 4,482,050 4,674,152”

Damora Therapeutics, Inc. shareholders approved Ratification of selection of Ernst & Young LLP as independent registered public accounting firm for fiscal year ending December 31, 2026 at the 2026-06-17 meeting.

“4. Ratification of Auditor Proposal . For Against Abstain Broker Non-Votes 54,977,317 5,640 26,981 -”

Damora Therapeutics, Inc. shareholders approved Advisory vote on the frequency of future advisory votes to approve executive compensation at the 2026-06-17 meeting.

“3. Say-on-Frequency Proposal . 1 Year 2 Years 3 Years Abstain 50,913,167 103 518,015 1,267”

Damora Therapeutics, Inc. shareholders approved Advisory vote to approve the compensation paid to the named executive officers at the 2026-06-17 meeting.

“2. Say-on-Pay Proposal . For Against Abstain Broker Non-Votes 51,401,988 3,546 27,018 3,577,386”

Damora Therapeutics, Inc. shareholders approved Election of Michael Landsittel and Cameron Turtle, D.Phil as Class III directors at the 2026-06-17 meeting.

“1. Election of Directors Proposal . Nominees For Withheld Broker Non-Votes Michael Landsittel 51,403,541 29,011 3,577,386 Cameron Turtle, D.Phil 51,403,540 29,012 3,577,386”

Deep Isolation Nuclear, Inc. shareholders approved Advisory vote on the frequency of future advisory votes on executive compensation at the 2026-06-16 meeting.

“4. To conduct an advisory vote on the frequency of future advisory votes on executive compensation : One Year Two Years Three Years Abstentions 30,329,791 16,666 1,028,106 3,259,999 The affirmative vote of the holders of a majority required for approval. The proposal was approved.”

Deep Isolation Nuclear, Inc. shareholders approved Advisory vote on executive compensation at the 2026-06-16 meeting.

“3. To conduct an advisory vote on executive compensation : Votes For Votes Against Abstentions 33,737,619 763,611 133,332 The affirmative vote of the holders of a majority required for approval. The proposal was approved.”

Deep Isolation Nuclear, Inc. shareholders approved Ratification of selection of CBIZ CPAs, P.C. as independent registered public accounting firm for year ending December 31, 2026 at the 2026-06-16 meeting.

“2. To provide an advisory vote to ratify the selection of CBIZ CPAs, P.C. as the independent registered public accounting firm of the Company for the year ending December 31, 2026 : Votes For Votes Against Abstentions 34,634,562 0 0 The affirmative vote of the holders of a majority required for approval. The proposal was approved.”

Deep Isolation Nuclear, Inc. shareholders approved Election of three Class A directors to serve until the 2029 Annual Meeting at the 2026-06-16 meeting.

“1. To elect three (3) Class A directors to serve until the 2029 Annual Meeting of Stockholders and until their respective successors have been duly elected and qualified: Name Votes For Withheld Rod Baltzer 34,634,562 0 Renee Hornbaker 34,634,562 0 Christa Steele 34,634,562 0 Each Class A director nominee was elected to serve as a director until the Company’s 2029 Annual Meeting of Stockholders, or until such person’s successor is duly elected and qualified, or until such person’s earlier resignation, death, or removal.”

IMMUCELL CORP /DE/ shareholders approved To ratify the Audit Committee’s selection of Wipfli LLP as the Independent Registered Public Accounting Firm of the Company for the year ending December 31, 2026. at the 2026-06-11 meeting.

“5. To ratify the Audit Committee’s selection of Wipfli LLP as the Independent Registered Public Accounting Firm of the Company for the year ending December 31, 2026: For Against Abstain Broker Non-votes 7,344,196 14,645 38,854 0 99.28% of the shares voting at this meeting in person or by proxy voted in favor. On the basis of this vote, the Audit Committee’s selection of Wipfli LLP as the Independent Registered Public Accounting Firm of the Company for the year ending December 31, 2026 was ratified.”

IMMUCELL CORP /DE/ shareholders approved To approve an amendment to the Company’s Certificate of Incorporation to reflect certain Delaware law provisions regarding the exculpation of officers. at the 2026-06-11 meeting.

“4. To approve an amendment to the Company’s Certificate of Incorporation to reflect certain Delaware law provisions regarding the exculpation of officers: For Against Abstain Broker Non-votes 4,851,019 325,531 11,244 2,209,901 53.62% of total shares outstanding voted in favor. On the basis of this vote, the amendment to the Company’s Certificate of Incorporation to reflect certain Delaware law provisions regarding the exculpation of officers was approved.”

IMMUCELL CORP /DE/ shareholders approved To approve the Company’s 2025 Stock Option and Incentive Plan. at the 2026-06-11 meeting.

“3. To approve the Company’s 2025 Stock Option and Incentive Plan: For Against Abstain Broker Non-votes 4,689,407 18,453 479,934 2,209,901 90.39% of the shares voting at this meeting in person or by proxy voted in favor. On the basis of this vote, the matter was approved.”

IMMUCELL CORP /DE/ shareholders approved To approve a non-binding advisory resolution on the Company’s executive compensation program. at the 2026-06-11 meeting.

“2. To approve a non-binding advisory resolution on the Company’s executive compensation program: For Against Abstain Broker Non-votes 4,793,553 29,155 365,086 2,209,901 92.4% of the shares voting at this meeting in person or by proxy voted in favor. On the basis of this vote, the non-binding advisory resolution on the Company’s executive compensation program was approved.”

IMMUCELL CORP /DE/ shareholders approved To elect to one-year terms as Directors of the Company the seven nominees listed in the 2026 Proxy Statement. at the 2026-06-11 meeting.

“1. To elect to one-year terms as Directors of the Company the nominees listed in the Company’s Proxy Statement dated April 24, 2026: For Withheld Broker Non-Votes Gloria J. Basse 5,177,979 9,815 2,209,901 P. Olivier te Boekhorst 5,180,197 7,597 2,209,901 Anthony A. Dimarco 5,179,503 8,291 2,209,901 Gilles Guillemette 5,166,860 20,934 2,209,901 David S. Tomsche 5,173,863 13,931 2,209,901 Kathy V. Turner 5,166,863 20,931 2,209,901 Paul R. Wainman 5,177,135 10,659 2,209,901 On the basis of this vote, each of the seven nominees was elected to a one-year term as a Director of the Company.”

ATN International, Inc. shareholders approved Ratification of independent registered public accounting firm at the 2026-06-16 meeting.

“Proposal 3 . Stockholders ratified the selection of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026. The voting results for the proposal were as follows: Number of Number of Number of Number of Shares Voted Shares Voted Shares Broker For Against Abstained Non-Votes 13,146,006 531,065 2,062 N/A”

ATN International, Inc. shareholders approved Advisory vote on executive compensation at the 2026-06-16 meeting.

“Proposal 2 . Stockholders approved, on a non-binding, advisory basis, the compensation of the Company’s named executive officers. The voting results for the proposal were as follows: Number of Number of Number of Number of Shares Voted Shares Voted Shares Broker For Against Abstained Non-Votes 11,499,717 538,209 4,056 1,637,151”

ATN International, Inc. shareholders approved Election of directors at the 2026-06-16 meeting.

“Proposal 1 . Stockholders elected each of the seven director nominees identified below to serve on the Board of Directors until the Company’s next annual meeting of stockholders and until their respective successors are elected and qualified, subject to their earlier retirement, resignation or removal. The voting results for each director nominee were as follows: Number of Number of Number of Number of Shares Voted Shares Voted Shares Broker Non- For Against Abstained Votes April V. Henry 10,949,860 1,089,540 2,582 1,637,151 Bernard J. Bulkin 11,881,861 134,685 25,436 1,637,151 Derek G. Hudson 10,937,497 1,078,812 25,673 1,637,151 Michael T. Prior 11,651,897 387,265 2,820 1,637,151 Naji N. Khoury 11,930,919 108,480 2,583 1,637,151 Pamela F. Lenehan 10,447,149 1,591,749 3,084 1,637,151 Patricia A. Jacobs 10,857,157 1,181,892 2,933 1,637,151”

Oak Valley Bancorp shareholders approved To ratify the appointment of RSM US LLP as the Company’s registered independent public accounting firm for the fiscal year ending December 31, 2026. at the 2026-06-16 meeting.

“2. To ratify the appointment of RSM US LLP as the Company’s registered independent public accounting firm for the fiscal year ending December 31, 2026. For Against Abstain Non-Votes 5,784,186 182,248 11,218 0”

Oak Valley Bancorp shareholders approved To re-elect four (4) members of the Board of Directors of the Company to serve until the expiration of their three (3) year term or until their successors are duly elected and qualified. at the 2026-06-16 meeting.

“1. To re-elect four (4) members of the Board of Directors of the Company to serve until the expiration of their three (3) year term or until their successors are duly elected and qualified. Number of Votes For Withheld Non-Votes Christopher M. Courtney 4,129,734 133,688 1,714,230 Lynn R. Dickerson 4,064,120 199,302 1,714,230 Allison C. Lafferty 4,126,142 137,280 1,714,230 Terrance P. Withrow 4,063,052 200,370 1,714,230”